Moderna has paused plans to build a vaccine manufacturing site in Kenya after a steep drop in demand for its Covid vaccines.
The biotech company said it has not received any vaccine orders for Africa since 2022 and has taken more than $1 billion in losses and write-downs related to the cancellation of previous orders from the continent. The biotech company said it has not received any vaccine orders for Africa since 2022 and has taken more than $1 billion in losses and write-downs related to the cancellation of previous orders from the continent.
Moderna's decision aligns with its broader effort to cut costs by resizing its Covid vaccine manufacturing footprint. The company's business took alast year as demand for those jabs waned worldwide, with people relying less on protective vaccines and treatments against the virus.in the Kenyan site and supply as many as 500 million doses of its messenger RNA vaccines to Africa each year. It also had plans to start filling doses of its Covid vaccine in the continent as early as 2023.
But the company has since determined that demand in Africa"is insufficient to support the viability of the factory planned in Kenya," Moderna said in a statement on Thursday. Still, the company said it is committed to"ensuring equitable access and meeting emerging demands from African nations" for its Covid shot through its global manufacturing network.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »
Source: FoxNews - 🏆 9. / 87 Read more »
Source: trtworld - 🏆 101. / 63 Read more »
Source: PolitiFact - 🏆 17. / 71 Read more »
Source: Slate - 🏆 716. / 51 Read more »
Source: FoxNews - 🏆 9. / 87 Read more »